Predictions
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€450.10
28.02.23
28.02.23
€569.31
28.02.24
28.02.24
1.53%
29.02.24
29.02.24
Henry Schein Inc.
Start price
Target price
Perf. (%)
€74.17
28.02.23
28.02.23
€91.27
28.02.24
28.02.24
-4.57%
29.02.24
29.02.24
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€289.75
29.05.23
29.05.23
-
29.05.24
29.05.24
22.71%
15.02.24
15.02.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€40.19
02.02.24
02.02.24
-
-
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€46.77
08.08.23
08.08.23
-
08.08.24
08.08.24
-23.22%
31.01.24
31.01.24
Johnson & Johnson
Start price
Target price
Perf. (%)
€153.36
24.01.23
24.01.23
€160.00
24.01.24
24.01.24
-4.60%
25.01.24
25.01.24
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.96
02.01.24
02.01.24
€80.00
02.02.24
02.02.24
-6.29%
22.01.24
22.01.24
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Grifols S.A.
Start price
Target price
Perf. (%)
€9.54
09.01.24
09.01.24
-
09.01.25
09.01.25
24.03%
10.01.24
10.01.24
Could be worthwhile Investment >10% per year
Good culture
Few uniques
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€529.00
18.12.23
18.12.23
€558.00
18.12.24
18.12.24
6.62%
06.01.24
06.01.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€68.08
03.01.23
03.01.23
-
03.01.24
03.01.24
-32.29%
28.12.23
28.12.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating